BUNKER KEVIN D. (Chief Operating Officer) sold 18.5% of their position (25K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $751.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2022ACC: 0001725160-22-000131
Officer· Chief Operating Officer
Since Apr 2020
-25K
Net shares
Net seller
$751.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−25K
Price / share
$30.07
Trade value
$751.65K
% of position
18.5%
7/5/2022
135K→110K
Total
Net shares
−25K
Net value
-$751.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/5/2022 | S · Sale | −25K | $30.07 | $751.65K | 18.5% | 135K | 110K |
| Total | −25K | -$751.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
DirectShares owned764.11K
Total
764.11K direct·350.00 indirect764.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 764.11K | Direct |
| Total | 764.46K | 764.11K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported